# Section 1557 and patient care decision support tools (45 CFR 92.210), explained

45 CFR 92.210 bars covered entities from discriminating through clinical decision tools, from flowcharts to AI models, and requires reasonable efforts to identify tools whose inputs measure protected traits and to mitigate the risk. The June 2026 vacatur notice does not list it.

Explainer · Healthcare · Data & AI. Published November 14, 2026. Last reviewed November 14, 2026.

## At a glance

- 45 CFR 92.210 came with HHS’s 2024 Section 1557 rule (89 FR 37522), effective July 5, 2024.
- Covered entities must not discriminate through patient care decision support tools, and must make reasonable efforts to identify tools whose inputs measure race, color, national origin, sex, age or disability, and to mitigate the risk.
- The identification and mitigation duties applied within 300 days of July 5, 2024.
- A tool is any automated or non-automated means used to support clinical decision-making. HHS said billing, coding, scheduling and staffing tools are outside it when unrelated to clinical decision-making affecting patient care.
- The June 2, 2026 notice (91 FR 32887) reports a court’s vacatur of gender identity provisions. Section 92.210 is not among the vacated provisions.
- As checked on November 14, 2026, the eCFR shows section 92.210 unchanged since July 5, 2024.

## What section 92.210 says

Section 1557 of the Affordable Care Act prohibits discrimination on the basis of race, color, national origin, sex, age or disability in health programs and activities that receive federal financial assistance [5]. HHS’s 2024 rule implementing it, “Nondiscrimination in Health Programs and Activities” (89 FR 37522, published May 6, 2024, effective July 5, 2024), added a section on clinical algorithms and similar tools, 45 CFR 92.210 [4]. It has three paragraphs [1]:

- **(a) General prohibition.** A covered entity must not discriminate on the basis of race, color, national origin, sex, age or disability in its health programs or activities through the use of patient care decision support tools.
- **(b) Identification of risk.** A covered entity has an ongoing duty to make reasonable efforts to identify uses of patient care decision support tools in its health programs or activities that employ input variables or factors that measure race, color, national origin, sex, age or disability.
- **(c) Mitigation of risk.** For each tool identified under (b), the covered entity must make reasonable efforts to mitigate the risk of discrimination resulting from the tool’s use.

## Who and what it covers

A covered entity is a recipient of federal financial assistance, HHS itself, or an entity established under title I of the Affordable Care Act [2]. The rule applies to every health program or activity any part of which receives federal financial assistance from HHS, directly or indirectly, to HHS’s own health programs, and to those administered by title I entities. It does not apply to an employer or other group health plan sponsor with regard to its employment practices, including employee health benefits [3]. Whether a given organization is covered is a question for its own counsel.

A patient care decision support tool is “any automated or non-automated tool, mechanism, method, technology, or combination thereof used by a covered entity to support clinical decision-making in its health programs or activities” [2]. The definition reaches beyond artificial intelligence. HHS’s proposed rule, quoted in the 2024 preamble, described clinical algorithms as ranging from flowcharts and clinical guidelines to complex computer algorithms, decision support interventions and models [4].

HHS also said what the section does not reach. It does not apply to tools used for decisions unrelated to clinical decision-making affecting patient care, such as administrative and billing activities, automated medical coding, fraud, waste and abuse, patient scheduling, facilities management, inventory and supply chain, investment management, or employment and staffing [4]. OCR also sought comment on whether to expand the scope of section 92.210 in further rulemaking, and if so, in what ways [4].

## When it applied

Paragraph (a) applied from July 5, 2024, the rule’s effective date. Covered entities had to comply with paragraphs (b) and (c) within 300 days of July 5, 2024 [3] [6].

## What “reasonable efforts” means in HHS’s explanation

The regulation does not list the steps. The preamble to the 2024 rule explains how the Office for Civil Rights (OCR) would judge compliance with the duty to identify. It may consider, among other factors [4]:

1. the covered entity’s size and resources: a large hospital with an IT department and a health equity officer would likely be expected to do more than a smaller provider;
2. whether the entity used the tool as the developer intended and as regulators approved, if applicable, or adapted or customized it;
3. whether the entity received information from the developer about the potential for discrimination, or identified that the tool’s inputs include a protected characteristic;
4. whether the entity has a method or process for evaluating the tools it adopts, which may include seeking information from the developer, reviewing medical literature, drawing on medical associations, or analyzing comments and complaints about the tools.

HHS set limits on the duty as well. Covered entities are not required to identify every tool whose inputs only indirectly measure a protected basis, though HHS urged caution with tools known to use such proxies. And the section does not require covered entities to obtain training datasets or other attribute information from developers [4]. On mitigation, HHS acknowledged that it is not always possible to eliminate the risk of discriminatory bias in these tools, and did not prescribe particular mitigation measures [4].

## The 2026 vacatur notice and what it does not touch

On June 2, 2026, OCR and CMS published a “Notice of Vacatur Regarding Certain Provisions of the 2024 Nondiscrimination in Health Programs and Activities Final Rule” (91 FR 32887) [5]. It reports that on October 22, 2025, the U.S. District Court for the Southern District of Mississippi, in *Tennessee v. Kennedy*, issued a final judgment vacating parts of the 2024 rule to the extent they expand Title IX’s definition of sex discrimination to include gender identity discrimination. The same court had preliminarily enjoined enforcement of those provisions on July 3, 2024 [5].

The notice lists the vacated provisions: 42 CFR 438.3(d)(4), 438.206(c)(2), 440.262, 460.98(b)(3) and 460.112(a), and 45 CFR 92.101(a)(2)(iv), 92.206(b)(1) through (4), 92.207(b)(3) through (5), 92.8(b)(1), 92.10(a)(1)(i) and 92.208 [5]. Section 92.210 is not on the list. The notice says that it does not apply to provisions the court did not vacate, nor to the listed provisions in respects other than the gender identity expansion, and that the other provisions of the 2024 rule remain in force [5]. It adds that it creates no legal obligations and no legal rights [5].

One link deserves care. Section 92.210 prohibits discrimination on the basis of sex, and the vacated section 92.101(a)(2)(iv) is the provision that said sex discrimination includes discrimination on the basis of gender identity [5]. The notice says OCR will not investigate or enforce the vacated provisions to the extent they made that expansion [5]. How that bears on a particular sex-based claim involving a decision support tool is a legal question for counsel. The notice does not list section 92.210 and says the rule’s other provisions remain in force [5].

As checked on November 14, 2026, the Electronic Code of Federal Regulations shows section 92.210 unchanged since July 5, 2024 [1].

## Turning the duty into a routine

Because the duty to identify is ongoing, it fits best as a standing process rather than a one-time review. A covered entity can keep an inventory of the clinical tools in use, including flowcharts and clinical guidelines as well as computer algorithms and models, flag those whose inputs measure a protected characteristic, record what it learned from developers and the literature, and record what it did to reduce the risk for each. Those steps mirror the factors OCR said it may consider [4]; the regulation itself does not prescribe them. Moraph’s teams help organizations with work like this; see our [solutions](https://www.moraph.com/solutions).

## Sources

1. Electronic Code of Federal Regulations. 45 CFR 92.210, Nondiscrimination in the use of patient care decision support tools (current text). <https://www.ecfr.gov/current/title-45/section-92.210> Checked November 14, 2026.
2. Electronic Code of Federal Regulations. 45 CFR 92.4, Definitions (current text). <https://www.ecfr.gov/current/title-45/section-92.4> Checked November 14, 2026.
3. Electronic Code of Federal Regulations. 45 CFR 92.1 and 92.2, Purpose and effective date; Application (current text). <https://www.ecfr.gov/current/title-45/part-92/subpart-A> Checked November 14, 2026.
4. Department of Health and Human Services, Federal Register (via GovInfo). Nondiscrimination in Health Programs and Activities (final rule, 89 FR 37522). <https://www.govinfo.gov/content/pkg/FR-2024-05-06/html/2024-08711.htm> Checked November 14, 2026.
5. HHS Office for Civil Rights and CMS, Federal Register (via GovInfo). Notice of Vacatur Regarding Certain Provisions of the 2024 Nondiscrimination in Health Programs and Activities Final Rule (91 FR 32887). <https://www.govinfo.gov/content/pkg/FR-2026-06-02/html/2026-11015.htm> Checked November 14, 2026.
6. Federal Register. Nondiscrimination in Health Programs and Activities: document details. <https://www.federalregister.gov/documents/2024/05/06/2024-08711/nondiscrimination-in-health-programs-and-activities> Checked November 14, 2026.

Published: November 14, 2026
Canonical URL: <https://insights.moraph.com/section-1557-patient-care-decision-support-tools-92-210-explained>
Publisher: Moraph Insights
